Lord, Abbett & Co’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-77,915
| Closed | -$3.72M | – | 711 |
|
|
2021
Q4 | $3.72M | Sell |
77,915
-376,353
| -83% | -$18M | 0.01% | 568 |
|
|
2021
Q3 | $30.2M | Sell |
454,268
-13,154
| -3% | -$874K | 0.07% | 354 |
|
|
2021
Q2 | $36.5M | Sell |
467,422
-636,374
| -58% | -$49.7M | 0.09% | 319 |
|
|
2021
Q1 | $104M | Sell |
1,103,796
-214,502
| -16% | -$20.3M | 0.27% | 111 |
|
|
2020
Q4 | $161M | Buy |
1,318,298
+471,812
| +56% | +$57.5M | 0.42% | 50 |
|
|
2020
Q3 | $73.9M | Buy |
846,486
+23,743
| +3% | +$2.07M | 0.24% | 128 |
|
|
2020
Q2 | $53.1M | Sell |
822,743
-162,295
| -16% | -$10.5M | 0.19% | 171 |
|
|
2020
Q1 | $44M | Buy |
985,038
+306,486
| +45% | +$13.7M | 0.19% | 161 |
|
|
2019
Q4 | $42.3M | Buy |
678,552
+346,770
| +105% | +$21.6M | 0.14% | 229 |
|
|
2019
Q3 | $12.5M | Buy |
331,782
+29,036
| +10% | +$1.09M | 0.04% | 489 |
|
|
2019
Q2 | $12.3M | Buy |
+302,746
| New | +$12.3M | 0.04% | 516 |
|